• SENSEX 82,188.99
    746.95 (+0.92%)
  • BANKNIFTY 56,578.40
    817.55 (+1.47%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Garden Reach Sh.
    3,199.05 1,180.10(%)
  • HDFC Bank
    1,996.30 1,996.30(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Reliance Power
    63.13 63.39(%)
  • Natl. Aluminium
    190.90 263.10(%)
  • HFCL
    92.19 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 46.00(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Sika Interplant
    1,265.00 399.96(%)
  • Multi Comm. Exc.
    7,529.95 7,529.95(%)
  • St Bk of India
    816.45 898.80(%)
  • Mazagon Dock
    3,380.30 1,417.20(%)
  • Hindustan Zinc
    510.75 717.10(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • REC Ltd
    417.30 653.90(%)
  • Eternal Ltd
    264.10 304.50(%)
  • Bharat Electron
    389.05 240.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Quest Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 92906.0
  • ISIN : INE0TNW01017
84.20 0 (0.24%)
  • As on 07 Jun 2025 (EOD)

  • Today’s Low

    81.35

  • Today’s High

    85.00

  • Open

    84.00

  • Perv Close

    84.00

  • 52W Low

    75.15

  • 52W High

    196.80

Key Indicators

  • P/E(TTM)

    10.17

  • Mar.Cap (₹Cr.)

    137.98

  • Div & Yield %

    0.00

  • Book Value(₹)

    49.92

  • Debt-Equity Ratio

    0.24

  • AGM Date

    06-Jun-2025

  • EPS

    8.28

  • P/E Ratio

    10.17

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    137.98

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.39

  • BV (₹)

    49.90

  • Sales( ₹ in Cr.)

    103.91

  • NP (in Cr.)

    13.57

  • NP Var(%)

    34.0

  • Div%

    0.0

  • CPS (₹)

    8.70

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    137.98

  • 52 Week High

    196.80

  • 52 Week Low

    75.15

  • Price BSE

    0.0

  • Price NSE

    84.00

  • Market Capital( in Cr.)

    137.98

  • P/C Ratio

    9.70

  • P/E Ratio

    10.10

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 82.56 61.64 59.48 30.36 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 82.56 61.64 59.48 30.36 - -
Other Income 0.23 0.23 0.06 0.07 - -
Stock Adjustments 0.04 -0.08 -0.22 -0.03 - -
Total Income 82.83 61.79 59.32 30.40 - -
EXPENDITURE :            
Raw Materials 52.29 41.72 44.27 24.43 - -
Power and Fuel Cost 0.87 0.79 0.58 0.40 - -
Employee Cost 3.64 2.80 3.04 2.11 - -
Other Manufacturing Expenses 0.30 0.30 0.30 0.23 - -
Selling and Administration Expenses 7.02 5.32 3.16 1.39 - -
Miscellaneous Expenses 2.92 2.75 1.44 0.35 - -
Employee Benefit Expenses 3.64 2.80 3.04 2.11 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 67.04 53.68 52.79 28.91 - -
Operating Profit 15.79 8.11 6.53 1.49 - -
Interest 0.78 0.58 0.30 0.31 - -
Gross Profit 15.01 7.53 6.23 1.18 - -
Depreciation 0.57 0.55 0.46 0.39 - -
Profit Before Tax 14.44 6.98 5.77 0.79 - -
Current Tax 4.21 1.79 1.55 0.15 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.15 0.15 0.11 -0.01 - -
Reported Net Profit 10.09 5.04 4.11 0.66 - -
Extraordinary Items 0.00 0.00 -0.02 0.00 - -
Adjusted Net Profit 10.09 5.04 4.13 0.66 - -
Adjustment below Net Profit -8.11 0.00 0.00 0.00 - -
P & L Balance brought forward 12.42 7.38 3.21 2.56 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 14.41 12.42 7.32 3.21 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 8.46 46.77 38.05 6.07 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 23.99 139.97 92.64 54.58 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    66.21%

  • Public Share Holding

    33.79%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 10,850,500 66.21 10,850,500 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,850,500 66.21 10,850,500 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 156,000 0.95 0 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 12,000 0.07 12,000 1
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 326,400 1.99 326,400 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 494,400 3.02 338,400 7
2] Non Institution
Bodies Corporate 480,000 2.93 480,000 18
Clearing Members 271,200 1.66 271,200 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 112,800 0.69 112,800 30
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 169,200 1.03 169,200 53
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,980,550 12.09 1,980,550 30
Individuals holding nominal share capital up to Rs. 1 lakh 2,009,350 12.26 2,009,350 858
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 19,200 0.12 19,200 1
Sub Total 5,042,300 30.77 5,042,300 991
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,387,200 100.00 16,231,200 1,001

Company Background

Quest Laboratories LtdPharmaceuticals - Indian - Formulations

  • Quest Laboratories Ltd
  • BSE Code : 92906.0
  • ISIN : INE0TNW01017

  • Incorporation Year

    1998

  • Registered Office

    Plot # 45 Sector III
    Pithampur, Dhar,
    Madhya Pradesh-454775

  • Telephone

    0729 2292 374

  • FAX

  • Chairman

    Mr Anil Kumar Sabarwal

  • Managing Director

    Mr Anil Kumar Sabarwal

  • Company Secretary

  • Auditor

    Shyam S. Gupta & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Quest Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Quest 84.20 82.79 82.56 10.17 57.51
Abbott India 31,751.10 6,097.18 5,848.91 47.70 44.71
Astrazeneca Phar 9,791.90 1,330.33 1,295.53 211.49 33.26
P & G Health Ltd 5,550.45 1,166.89 1,151.26 36.68 39.76
Glaxosmi. Pharma 3,431.50 3,866.05 3,723.49 63.25 58.72
Cipla 1,503.75 17,645.00 16,574.34 23.55 20.10
Amrutanjan Healt 714.85 437.58 421.23 40.66 20.84
Guj. Themis Bio. 322.55 174.19 169.82 72.00 44.82
Fermenta Biotec. 321.90 315.24 307.09 14.01 4.10
Bliss GVS Pharma 136.50 638.96 605.46 20.84 11.19
Ambalal Sarabhai 35.88 11.70 3.81 33.22 1.92